Tissue Tek O.C.T. Compound

Tissue Tek O.C.T. Compound 

To Order Contact us: lieven@wlsolutions.be

Compound W
2208-250
EUR 300

Compound W
2208-50
EUR 115

Compound 112254
2573-25
EUR 588

Compound 112254
2573-5
EUR 185

Compound 401
1657-5
EUR 238

Compound 1
1688-5
EUR 207

Compound 34
1898-1000
EUR 457

Compound 34
1898-200
EUR 158

Compound E
1949-1000
EUR 370

Compound E
1949-250
EUR 153

Compound CL0485
ADC-P-074 unit Ask for price

Compound 401
B7337-10 10 mg
EUR 224

Compound 401
B7337-25 25 mg
EUR 441

Compound 401
B7337-5 5 mg
EUR 180

Compound W
A4401-50 50 mg
EUR 177
Description: Inhibitor of ?-secretase; causes a decrease in the released levels of A?42 and notch-1 A?-like peptide 25 (N?25).

Compound 56
A8197-.5 500 µg
EUR 108
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56
A8197-5 5 mg
EUR 224
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56
A8197-5.1 10 mM (in 1mL DMSO)
EUR 270
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound 56
A8197-S Evaluation Sample
EUR 81
Description: Compound 56, 4-[(3-Bromophenyl)amino]-6,7-diethoxyquinazoline, is a potent and specific inhibitor of the tyrosine kinase of the epidermal growth factor receptor (EGFR) showing an IC50 of 0.006 nM.

Compound E
HY-14176 10mM/1mL
EUR 694

Compound 401
HY-19341 10mM/1mL
EUR 186

Compound 34
GL2080-1MG 1 mg
EUR 373

Compound 34
GL2080-200UG 200 ug
EUR 166

Compound 112254
GL3740-10MG 10 mg
EUR 166

Compound 112254
GL3740-50MG 50 mg
EUR 459

Compound E
GL3746-1MG 1 mg
EUR 378

Compound E
GL3746-250UG 250 ug
EUR 172

Compound E
GL3746-5MG 5 mg
EUR 998

Compound 2
HY-U00358 10mg
EUR 6041

Compound K
N1890-20 20 mg
EUR 340
Description: Compound K

Imidazoquinoline Compound
VAdv-Ly0028 5 mg
EUR 3280
Description: Imidazoquinoline compound, a TLR7 agonist vaccine adjuvant.

TEK antibody
70R-20759 50 ul
EUR 435
Description: Rabbit polyclonal TEK antibody

TEK Antibody
37274-100ul 100ul
EUR 252

TEK Antibody
1-CSB-PA050236
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against TEK. Recognizes TEK from Human, Mouse. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/5000

TEK Antibody
1-CSB-PA050237
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against TEK. Recognizes TEK from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

TEK Antibody
1-CSB-PA982820
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
  • Form: Liquid
  • Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Antigen affinity purification
Description: A polyclonal antibody against TEK. Recognizes TEK from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:3000-1:10000, IHC:1:50-1:200

TEK Antibody
1-CSB-PA041300
  • EUR 317.00
  • EUR 244.00
  • 100ul
  • 50ul
  • Form: Liquid
  • Buffer: -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Antigen affinity purification
Description: A polyclonal antibody against TEK. Recognizes TEK from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100

TEK Antibody
1-CSB-PA023375GA01HU
  • EUR 597.00
  • EUR 333.00
  • 150ul
  • 50ul
  • Form: Liquid
  • Buffer: PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20℃, Avoid freeze / thaw cycles. Antigen Affinity purified
Description: A polyclonal antibody against TEK. Recognizes TEK from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

TEK siRNA
20-abx936459
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol
  • Shipped within 5-10 working days.

anti-TEK
YF-PA27377 50 ug
EUR 363
Description: Mouse polyclonal to TEK

Dorsomorphin (Compound C)
B3252-10 10 mg
EUR 137
Description: Dorsomorphin is a cell-permeable and reversible ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) with Ki value of 109nM [1].Dorsomorphin is highly selective against AMPK over other structure related kinases such as protein kinase A, protein kinase C and Janus kinase 3.

Dorsomorphin (Compound C)
B3252-5 5 mg
EUR 108
Description: Dorsomorphin is a cell-permeable and reversible ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) with Ki value of 109nM [1].Dorsomorphin is highly selective against AMPK over other structure related kinases such as protein kinase A, protein kinase C and Janus kinase 3.

Dorsomorphin (Compound C)
B3252-50 50 mg
EUR 340
Description: Dorsomorphin is a cell-permeable and reversible ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) with Ki value of 109nM [1].Dorsomorphin is highly selective against AMPK over other structure related kinases such as protein kinase A, protein kinase C and Janus kinase 3.

Teijin compound 1
B5468-10 10 mg
EUR 389

Teijin compound 1
B5468-50 50 mg
EUR 1476

GPR120 Compound A
C5824-10 10 mg
EUR 293
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

GPR120 Compound A
C5824-5 5 mg
EUR 197
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

GPR120 Compound A
C5824-50 50 mg
EUR 920
Description: GPR120 Compound A is an orally active and high-affinity agonist of GPR120 [1].G-protein coupled receptor 120 is a G protein-coupled receptor which has been expressed in intestine, adipocytes, and pro-inflammatory macrophages that is activated by long chain free fatty acids.

Antibacterial compound 2
HY-101730 5mg
EUR 7984

Antibacterial compound 1
HY-101819 5mg
EUR 2198

Teijin compound 1
HY-108323 5mg
EUR 312

Compound 112254 hydrochloride
GL8859-10MG 10 mg
EUR 166

Compound 112254 hydrochloride
GL8859-50MG 50 mg
EUR 459

Antiasthmatic Compound 1
HY-U00409 1mg
EUR 849

APHA Compound 8
M45003 1 mg
EUR 284.9
Description: Ask the seller for details

TEK Rabbit pAb
A0743-100ul 100 ul
EUR 308

TEK Rabbit pAb
A0743-200ul 200 ul
EUR 459

TEK Rabbit pAb
A0743-20ul 20 ul
EUR 183

TEK Rabbit pAb
A0743-50ul 50 ul
EUR 223

TEK Conjugated Antibody
C37274 100ul
EUR 397

TEK Rabbit pAb
A7222-100ul 100 ul
EUR 308

TEK Rabbit pAb
A7222-200ul 200 ul
EUR 459

TEK Rabbit pAb
A7222-20ul 20 ul
EUR 183

TEK Rabbit pAb
A7222-50ul 50 ul
EUR 223

Anti-TEK antibody
STJ25807 100 µl
EUR 277
Description: This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known.

Anti-TEK antibody
STJ29302 100 µl
EUR 277
Description: This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known.

Anti-TEK Antibody
STJ503257 100 µg
EUR 476

Anti-TEK Antibody
STJ503258 100 µg
EUR 476

8-hydroxy Guanosine, compound
8OHG15-N-1 1 mg
EUR 202

8-hydroxy Guanosine, compound
8OHG15-N-5 5 mg
EUR 590

PKM2 inhibitor(compound 3k)
B8217-25 25 mg
EUR 412

PKM2 inhibitor(compound 3k)
B8217-5 5 mg
EUR 168

CCT251545 analogue, Compound 51
A8739-25 25 mg
EUR 1442
Description: CCT251545 analogue, Compound 51 is a potent and selective CDK8/19 inhibitor with IC50 values of 5.1 nM and 5.6 nM, respectively [1]. Mediator complex-associated kinases CDK8 and CDK19 are involved in the regulation of multiple transcription pathways.

CCT251545 analogue, Compound 51
A8739-5 5 mg
EUR 456
Description: CCT251545 analogue, Compound 51 is a potent and selective CDK8/19 inhibitor with IC50 values of 5.1 nM and 5.6 nM, respectively [1]. Mediator complex-associated kinases CDK8 and CDK19 are involved in the regulation of multiple transcription pathways.

Arrhythmias-Targeting Compound 1
HY-101750 20mg
EUR 5683

NPS ALX Compound 4a
HY-103090 5mg
EUR 291

Cancer-Targeting Compound 1
HY-U00300 1mg
EUR 849

Neuromuscular-targeting compound 1
HY-U00310 20mg
EUR 4803

Itch-Targeting Compound 1
HY-U00361 20mg
EUR 11180

Arrhythmic-Targeting Compound 1
HY-U00393 5mg
EUR 9361

Asthma relating compound 1
HY-U00412 5mg
EUR 2846

DiscoveryProbe? Bioactive Compound Library
L1022-.1 100 uL/well(10 mM solution)
EUR 23389

DiscoveryProbe? Bioactive Compound Library
L1022-.25 250 uL/well(10 mM solution)
EUR 42042

DiscoveryProbe? Bioactive Compound Library
L1022-5 5 mg/well
EUR 54686

DiscoveryProbe? GPCR Compound Library
L1025-.1 100 uL/well(10 mM solution)
EUR 4736

DiscoveryProbe? GPCR Compound Library
L1025-.25 250 uL/well(10 mM solution)
EUR 8518

DiscoveryProbe? GPCR Compound Library
L1025-5 5 mg/well
EUR 11070

DiscoveryProbe? Epigenetics Compound Library
L1029-.1 100 uL/well(10 mM solution)
EUR 5954

DiscoveryProbe? Epigenetics Compound Library
L1029-.25 250 uL/well(10 mM solution)
EUR 10722

DiscoveryProbe? Epigenetics Compound Library
L1029-5 5 mg/well
EUR 13970

DiscoveryProbe? Autophagy Compound Library
L1031-.1 100 uL/well(10 mM solution)
EUR 11174

DiscoveryProbe? Autophagy Compound Library
L1031-.25 250 uL/well(10 mM solution)
EUR 20118

DiscoveryProbe? Autophagy Compound Library
L1031-5 5 mg/well
EUR 26150

DiscoveryProbe? Apoptosis Compound Library
L1036-.1 100 uL/well(10 mM solution)
EUR 3472

DiscoveryProbe? Apoptosis Compound Library
L1036-.25 250 uL/well(10 mM solution)
EUR 6198

DiscoveryProbe? Apoptosis Compound Library
L1036-5 5 mg/well
EUR 8054

Phospho-TEK (Y1108) Antibody
1-CSB-PA050234
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against Phospho-TEK (Y1108). Recognizes Phospho-TEK (Y1108) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/20000

Phospho-TEK (Y1102) Antibody
1-CSB-PA050235
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against Phospho-TEK (Y1102). Recognizes Phospho-TEK (Y1102) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000

Phospho-TEK (Y992) Antibody
1-CSB-PA006341
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
  • Form: Liquid
  • Buffer: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Description: A polyclonal antibody against Phospho-TEK (Y992). Recognizes Phospho-TEK (Y992) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

Anti-TIE2/TEK Antibody
A01274-1 100ug/vial
EUR 334

Anti-TIE2/TEK Antibody
A01274-2 100ug/vial
EUR 334

Human TEK ELISA Kit
ELA-E0126h 96 Tests
EUR 824

Human TEK shRNA Plasmid
20-abx954787
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg
  • Shipped within 15-20 working days.

Anti-TIE2/TEK Antibody
RP1036 100ug/vial
EUR 294

Anti-TEK Antibody (Biotin)
STJ503259 100 µg
EUR 586

Anti-TEK Antibody (FITC)
STJ503260 100 µg
EUR 586

Anti-TEK Antibody (Biotin)
STJ503261 100 µg
EUR 586

Anti-TEK Antibody (FITC)
STJ503262 100 µg
EUR 586

NPS ALX Compound 4a dihydrochloride
B7344-10 10 mg
EUR 366

NPS ALX Compound 4a dihydrochloride
B7344-50 50 mg
EUR 1379

Imidazol-1-yl compound 1
HY-U00322 10mg
EUR 3700

Urinary Incontinence-Targeting Compound 1
HY-U00357 1mg
EUR 2089

Neurodegenerative Disorder-Targeting Compound 1
HY-U00362 5mg
EUR 3577

Neuromuscular Disorder-Targeting Compound 1
HY-U00385 1mg
EUR 3438

DiscoveryProbe? Anti-cancer Compound Library
L1023-.1 100 uL/well(10 mM solution)
EUR 20303

DiscoveryProbe? Anti-cancer Compound Library
L1023-.25 250 uL/well(10 mM solution)
EUR 36474

DiscoveryProbe? Anti-cancer Compound Library
L1023-5 5 mg/well
EUR 47378

DiscoveryProbe? Anti-infection Compound Library
L1027-.1 100 uL/well(10 mM solution)
EUR 7033

DiscoveryProbe? Anti-infection Compound Library
L1027-.25 250 uL/well(10 mM solution)
EUR 12578

DiscoveryProbe? Anti-infection Compound Library
L1027-5 5 mg/well
EUR 16290

DiscoveryProbe? Ion Channel Compound Library
L1030-.1 100 uL/well(10 mM solution)
EUR 5560

DiscoveryProbe? Ion Channel Compound Library
L1030-.25 250 uL/well(10 mM solution)
EUR 9886

DiscoveryProbe? Ion Channel Compound Library
L1030-5 5 mg/well
EUR 12902

DiscoveryProbe? Metabolism-related Compound Library
L1032-.1 100 uL/well(10 mM solution)
EUR 8576

DiscoveryProbe? Metabolism-related Compound Library
L1032-.25 250 uL/well(10 mM solution)
EUR 15362

DiscoveryProbe? Metabolism-related Compound Library
L1032-5 5 mg/well
EUR 20002

DiscoveryProbe? Stem Cell Compound Library
L1040-.1 100 uL/well(10 mM solution)
EUR 4353

DiscoveryProbe? Stem Cell Compound Library
L1040-.25 250 uL/well(10 mM solution)
EUR 7822

DiscoveryProbe? Stem Cell Compound Library
L1040-5 5 mg/well
EUR 10142

DiscoveryProbe? JAK/STAT Compound Library
L1041-.1 100 uL/well(10 mM solution)
EUR 2254

DiscoveryProbe? JAK/STAT Compound Library
L1041-.25 250 uL/well(10 mM solution)
EUR 3994

DiscoveryProbe? JAK/STAT Compound Library
L1041-5 5 mg/well
EUR 5154

DiscoveryProbe? Immunology/Inflammation Compound Library
L1042-.1 100 uL/well(10 mM solution)
EUR 3390

DiscoveryProbe? Immunology/Inflammation Compound Library
L1042-.25 250 uL/well(10 mM solution)
EUR 6082

DiscoveryProbe? Immunology/Inflammation Compound Library
L1042-5 5 mg/well
EUR 7938

DiscoveryProbe? Anti-diabetic Compound Library
L1046-.1 100 uL/well(10 mM solution)
EUR 722

DiscoveryProbe? Anti-diabetic Compound Library
L1046-.25 250 uL/well(10 mM solution)
EUR 1256

DiscoveryProbe? Anti-diabetic Compound Library
L1046-5 5 mg/well
EUR 1616

S-Nitroso-L-Glutathione, compound
SNOG15-N-10 10 mg
EUR 250

S-Nitroso-L-Glutathione, compound
SNOG15-N-5 5 mg
EUR 189

Clarithromycin related compound Z EvoPure®
E022-10MG 10 mg
EUR 670

8-hydroxy-2-deoxy Guanosine, compound
8OH2G16-N-1 1 mg
EUR 238

8-hydroxy-2-deoxy Guanosine, compound
8OH2G16-N-5 5 mg
EUR 590

Clarithromycin related compound C EvoPure®
C128-10MG 10 mg
EUR 368

Clarithromycin related compound I EvoPure®
C131-10MG 10 mg
EUR 368

Clarithromycin related compound J EvoPure®
C132-10MG 10 mg
EUR 368

Clarithromycin related compound K EvoPure®
C133-10MG 10 mg
EUR 368

Clarithromycin related compound L EvoPure®
C134-10MG 10 mg
EUR 670

Clarithromycin related compound M EvoPure®
C135-5MG 5 mg
EUR 223

Clarithromycin related compound D EvoPure®
C140-5MG 5 mg
EUR 344

Clarithromycin related compound H EvoPure®
C143-5MG 5 mg
EUR 486

DiscoveryProbe? PI3K/Akt/mTOR Compound Library
L1034-.1 100 uL/well(10 mM solution)
EUR 3750

DiscoveryProbe? PI3K/Akt/mTOR Compound Library
L1034-.25 250 uL/well(10 mM solution)
EUR 6662

Tissue Tek O.C.T. Compound